Serialization and Anti-Counterfeiting in Pharma Supply Chains

A counterfeit or diverted medicine looks, on the shelf, exactly like the genuine product next to it — which is precisely why the pharmaceutical industry has spent the past two decades building systems that do not rely on how a pack looks. Serialization is the core of that effort: assigning each individual saleable unit a unique, machine-readable identifier so its authenticity and history can be checked electronically rather than assumed from appearance.

What Serialization Actually Means

At its simplest, serialization means printing a unique code — typically a 2D data matrix — on each pack, encoding a product identifier, batch number, expiry date and a unique serial number for that specific unit. No two packs of the same product share the same serial number. This is a meaningful step beyond a standard batch or lot number, which is shared by potentially thousands of units and only narrows a problem to "somewhere in this batch." A serial number narrows it to one physical pack.

Above the individual pack, many systems also use aggregation: linking serialized units to the case and pallet they are packed into, so that scanning one higher-level barcode can confirm what should be inside it. Aggregation is what makes large-volume verification practical — a warehouse does not need to scan every individual carton if the case-level record is trustworthy.

The Problem the System Is Designed to Address

Falsified medicines — products that misrepresent their identity, source or history, whether wholly fake, diverted from another market, or repackaged after tampering — can enter a supply chain at points where oversight is weakest: informal secondary wholesalers, cross-border diversion, or gaps between legitimate handlers. Because the risk is illustrative rather than a fixed global figure, most regulators frame it broadly: a small but real share of the medicines supply chain, concentrated in specific product categories and markets, is vulnerable to this kind of intrusion. Serialization does not physically stop a counterfeit from being manufactured; it makes a counterfeit or diverted unit detectable the moment someone in the legitimate chain checks it against the system of record.

Verification Along the Chain

The value of a unique identifier depends entirely on whether it gets checked. In a mature system:

• Manufacturers upload each serial number to a national or regional repository at the point of production.
• Wholesalers and distributors can scan incoming stock against that repository to confirm a code exists, has not already been used, and matches the expected product.
• At the point of dispense, the code is typically decommissioned — marked as used — so the same serial number cannot be presented again elsewhere.

This last step is what closes the loop: a copied or reused code fails verification the second time it appears, even if the physical counterfeit is a convincing visual match.

Tamper-Evident Packaging as a Complementary Layer

Serialization is a digital control; tamper-evident packaging is its physical counterpart. A safety feature — a seal, perforation, or closure that visibly breaks on first opening — gives a handler or patient a way to notice interference without needing a scanner at all. The two layers address different failure modes:

| Layer | Detects | Requires | |---|---|---| | Serialization / verification | Diverted, falsified or duplicated identity | A scan against a repository | | Tamper-evident packaging | Physical opening or resealing after manufacture | Visual inspection only |

Neither layer substitutes for the other; regulatory frameworks in many markets require both precisely because each covers a gap the other leaves open.

What This Means for Distributors and Buyers

For a distributor, participating honestly in a serialization system is an operational discipline as much as a compliance one: scanning incoming stock rather than trusting paperwork, reporting a verification failure rather than working around it, and keeping the systems that talk to national repositories properly maintained. For an institutional buyer, a supplier's willingness to explain — concretely — how its serialization and verification process works is a more useful signal than a general assurance that "the product is genuine."

The Takeaway

Serialization turns a claim about a medicine's authenticity into something that can be checked rather than trusted on sight. Combined with tamper-evident packaging, it gives every handler in the chain, from manufacturer to point of dispense, a practical way to catch a falsified or diverted product before it reaches a patient.

This is general educational information, not legal or regulatory advice; consult the current official texts and your competent authority.